Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gang Greg Wang

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Trends in Genetics : TIG|January 26, 2021
Polycomb Gene Silencing Mechanisms: PRC2 Chromatin Targeting, H3K27me3 'Readout', and Phase Separation-Based CompactionYiran Guo, Shuai Zhao, Gang Greg Wang
Cancer Treatment and Research|December 19, 2023
Polycomb Repressive Complex 2 in OncologyYiran Guo, Yao Yu, Gang Greg Wang
Cellular and Molecular Life Sciences : CMLS|June 1, 2019
Understanding histone H3 lysine 36 methylation and its deregulation in diseaseJie Li, Jeong Hyun Ahn, Gang Greg Wang
Nature Reviews. Cancer|June 25, 2010
Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancersPing Chi, C David Allis, Gang Greg Wang
Nature Reviews. Cancer|May 18, 2021
The language of chromatin modification in human cancersShuai Zhao, C David Allis, Gang Greg Wang
Blood|January 9, 2015
Polycomb genes, miRNA, and their deregulation in B-cell malignanciesGang Greg Wang, Kyle D Konze, Jianguo Tao
Medscience|April 1, 2026
Mono-ubiquitination of histone H2A lysine 119 (H2AK119Ub): its multifaceted role in biology and implication in diseasesDamu Wu, Haiqing Zhong, Ling Cai, et al.
Experimental Hematology|June 2, 2015
Targeting EZH2 and PRC2 dependence as novel anticancer therapyBowen Xu, Kyle D Konze, Jian Jin, et al.
Trends in Cancer|June 22, 2023
Onco-condensates: formation, multi-component organization, and biological functionsChenxi Xu, Arum Kim, Joshua M Corbin, et al.
Current Opinion in Genetics & Development|April 15, 2022
Oncogenic fusion proteins and their role in three-dimensional chromatin structure, phase separation, and cancerIvana Y Quiroga, Jeong Hyun Ahn, Gang Greg Wang, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Trends in Genetics : TIG|January 26, 2021
Polycomb Gene Silencing Mechanisms: PRC2 Chromatin Targeting, H3K27me3 'Readout', and Phase Separation-Based CompactionYiran Guo, Shuai Zhao, Gang Greg Wang
Cancer Treatment and Research|December 19, 2023
Polycomb Repressive Complex 2 in OncologyYiran Guo, Yao Yu, Gang Greg Wang
Cellular and Molecular Life Sciences : CMLS|June 1, 2019
Understanding histone H3 lysine 36 methylation and its deregulation in diseaseJie Li, Jeong Hyun Ahn, Gang Greg Wang
Nature Reviews. Cancer|June 25, 2010
Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancersPing Chi, C David Allis, Gang Greg Wang
Nature Reviews. Cancer|May 18, 2021
The language of chromatin modification in human cancersShuai Zhao, C David Allis, Gang Greg Wang
Blood|January 9, 2015
Polycomb genes, miRNA, and their deregulation in B-cell malignanciesGang Greg Wang, Kyle D Konze, Jianguo Tao
Medscience|April 1, 2026
Mono-ubiquitination of histone H2A lysine 119 (H2AK119Ub): its multifaceted role in biology and implication in diseasesDamu Wu, Haiqing Zhong, Ling Cai, et al.
Experimental Hematology|June 2, 2015
Targeting EZH2 and PRC2 dependence as novel anticancer therapyBowen Xu, Kyle D Konze, Jian Jin, et al.
Trends in Cancer|June 22, 2023
Onco-condensates: formation, multi-component organization, and biological functionsChenxi Xu, Arum Kim, Joshua M Corbin, et al.
Current Opinion in Genetics & Development|April 15, 2022
Oncogenic fusion proteins and their role in three-dimensional chromatin structure, phase separation, and cancerIvana Y Quiroga, Jeong Hyun Ahn, Gang Greg Wang, et al.
Pageof 9